The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Gender Related Changes in Gene Expression Induced by Valproic Acid in A Mouse Model of Autism and the Correction by S-adenosyl Methionine. Does It Explain the Gender Differences in Autistic Like Behavior?
Abstract
In previous studies we produced autism like behavioral changes in mice by Valproic acid (VPA) with significant differences between genders. S-adenosine methionine (SAM) prevented the autism like behavior in both genders. The expression of 770 genes of pathways involved in neurophysiology and neuropathology was studied in the prefrontal cortex of 60 days old male and female mice using the NanoString nCounter. In females, VPA induced statistically significant changes in the expression of 146 genes; 71 genes were upregulated and 75 downregulated. In males, VPA changed the expression of only 19 genes, 16 were upregulated and 3 downregulated. Eight genes were similarly changed in both genders. When considering only the genes that were changed by at least 50%, VPA changed the expression of 15 genes in females and 3 in males. Only Nts was similarly downregulated in both genders. SAM normalized the expression of most changed genes in both genders. We presume that genes that are involved in autism like behavior in our model were similarly changed in both genders and corrected by SAM. The behavioral and other differences between genders may be related to genes that were differently affected by VPA in males and females and/or differently affected by SAM.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Further studies revealed changes in the expression of 146 neuropathology and neurophysiology genes, some of them known to be involved in the neuropathology of ASD [76].”
From Animal Models of Autistic-like Behavior in Rodents: A Scoping Review and Call for a Comprehensive Scoring System (2024) · cites this paper as [76]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Christensen, D. L., Baio, J., Braun, K. V. N., Bilder, D., Charles, J., Constantino, J. N., Daniels, J., Durkin, M. S., Fitzgerald, R. T., Kurzius-Spencer, M., et al. (2016) · MMWR. Surveillance Summaries · doi:10.15585/mmwr.ss6503a1 · Cited by 1,964
RetractedModerated estimation of fold change and dispersion for RNA-seq data with DESeq2
Love, M. I., Huber, W., & Anders, S. (2014) · Genome Biology · doi:10.1186/s13059-014-0550-8 · Cited by 95,106
What Is the Male-to-Female Ratio in Autism Spectrum Disorder? A Systematic Review and Meta-Analysis
Loomes, R., Hull, L., & Mandy, W. P. L. (2017) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2017.03.013 · Cited by 2,804 · cited 1×
“of diagnosis is also on average later in autistic females than males, and females may often be missed by current diagnostic procedures [9].”
BackgroundVan Wijngaarden-Cremers, P. J. M., van Eeten, E., Groen, W. B., Van Deurzen, P. A., Oosterling, I. J., & Van der Gaag, R. J. (2014) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-013-1913-9 · Cited by 547
Valproic acid in pregnancy: how much are we endangering the embryo and fetus?
Ornoy, A. (2009) · Reproductive Toxicology · doi:10.1016/j.reprotox.2009.02.014 · Cited by 526
Self-citationCharacteristics of fetal anticonvulsant syndrome associated autistic disorder
Rasalam, A., Hailey, H., Williams, J., Moore, S., Turnpenny, P., Lloyd, D., & Dean, J. (2005) · Developmental Medicine & Child Neurology · doi:10.1017/s0012162205001076 · Cited by 456
Adjunctive Nutraceuticals for Depression: A Systematic Review and Meta-Analyses
Sarris, J., Murphy, J., Mischoulon, D., Papakostas, G. I., Fava, M., Berk, M., & Ng, C. H. (2016) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2016.15091228 · Cited by 436
Ingram, J. L., Peckham, S. M., Tisdale, B., & Rodier, P. M. (2000) · Neurotoxicology and Teratology · doi:10.1016/s0892-0362(99)00083-5 · Cited by 381
Kataoka, S., Takuma, K., Hara, Y., Maeda, Y., Ago, Y., & Matsuda, T. (2013) · International Journal of Neuropsychopharmacology · doi:10.1017/s1461145711001714 · Cited by 341
Prenatal factors associated with autism spectrum disorder (ASD)
Ornoy, A., Weinstein-Fudim, L., & Ergaz, Z. (2015) · Reproductive Toxicology · doi:10.1016/j.reprotox.2015.05.007 · Cited by 238
Self-citation
Research works printed but not linked: 116
- Baio, 2018, Prevalence of Autism Spectrum Disorder Among Children Aged 8 Years—Autism and Developmental Disabilities Monitoring Network, 11 Sites, United States, 2014, MMWR Surveill. Summ., 67, 1, 10.15585/mmwr.ss6706a1 · DOI · Paper page
- Lai, 2015, Sex/gender differences and autism: Setting the scene for future research, J. Am. Acad. Child Adolesc. Psychiatry, 54, 11, 10.1016/j.jaac.2014.10.003 · DOI · Paper page
- Beggiato, 2017, Gender differences in autism spectrum disorders: Divergence among specific core symptoms, Autism Res., 10, 680, 10.1002/aur.1715 · DOI · Paper page
- Rodier, 1996, Embryological origin for autism: Developmental anomalies of the cranial nerve motor nuclei, J. Comp. Neurol., 370, 247, 10.1002/(SICI)1096-9861(19960624)370:2<247::AID-CNE8>3.0.CO;2-2 · doi:10.1002/(sici)1096-9861(19960624)370:2<247::aid-cne8>3.0.co;2-2
- Silberstein, 2009, Preventive migraine treatment, Neurol. Clin., 27, 429, 10.1016/j.ncl.2008.11.007 · DOI · Paper page
- Post, 2011, Tolerance to the prophylactic effects of carbamazepine and related mood stabilizers in the treatment of bipolar disorders, CNS Neurosci., 17, 649, 10.1111/j.1755-5949.2010.00215.x · DOI
- Williams, 2001, Fetal valproate syndrome and autism: Additional evidence of an association, Dev. Med. Child Neurol., 43, 202, 10.1111/j.1469-8749.2001.tb00188.x · DOI · Paper page
- Wagner, 2006, A New Neurobehavioral Model of Autism in Mice: Pre- and Postnatal Exposure to Sodium Valproate, J. Autism Dev. Disord., 36, 779, 10.1007/s10803-006-0117-y · DOI · Paper page
- Rodrigues, 2011, Animal model of autism induced by prenatal exposure to valproate: Behavioral changes and liver parameters, Brain Res., 1408, 8, 10.1016/j.brainres.2011.06.015 · DOI · Paper page
- Kolozsi, 2009, Prenatal exposure to valproic acid leads to reduced expression of synaptic adhesion molecule neuroligin 3 in mice, Neuroscience, 163, 1201, 10.1016/j.neuroscience.2009.07.021 · DOI · Paper page
- Rodier, 1997, Linking etiologies in humans and animal models: Studies of autism, Reprod. Toxicol., 11, 417, 10.1016/S0890-6238(97)80001-U · DOI · Paper page
- Nicolini, 2018, The valproic acid-induced rodent model of autism, Exp. Neurol., 299, 217, 10.1016/j.expneurol.2017.04.017 · DOI · Paper page
- Jeon, 2018, Sex-specific Behavioral Features of Rodent Models of Autism Spectrum Disorder, Exp. Neurobiol., 27, 321, 10.5607/en.2018.27.5.321 · DOI · Paper page
- Ornoy, 2019, S-adenosyl methionine prevents ASD like behaviors triggered by early postnatal valproic acid exposure in very young mice, Neurotoxicol. Teratol., 71, 64, 10.1016/j.ntt.2018.01.005 · DOI · Paper page
- Schneider, 2008, Gender-specific behavioral and immunological alterations in an animal model of autism induced by prenatal exposure to valproic acid, Psychoneuroendocrinology, 33, 728, 10.1016/j.psyneuen.2008.02.011 · DOI · Paper page
- Kazlauskas, 2019, Sex-specific effects of prenatal valproic acid exposure on sociability and neuroinflammation: Relevance for susceptibility and resilience in autism, Psychoneuroendocrinology, 110, 104441, 10.1016/j.psyneuen.2019.104441 · DOI
- Sailer, 2019, Consequences of prenatal exposure to valproic acid in the socially monogamous prairie voles, Sci. Rep., 9, 2453, 10.1038/s41598-019-39014-7 · DOI
- Mabunga, 2015, Exploring the Validity of Valproic Acid Animal Model of Autism, Exp. Neurobiol., 24, 285, 10.5607/en.2015.24.4.285 · DOI · Paper page
- Choi, 2016, The transgenerational inheritance of autism-like phenotypes in mice exposed to valproic acid during pregnancy, Sci. Rep., 6, 36250, 10.1038/srep36250 · DOI
- Nowakowska, 2019, Genetics and epigenetics of autism spectrum disorder-current evidence in the field, J. Appl. Genet., 60, 37, 10.1007/s13353-018-00480-w · DOI · Paper page
- Lauber, 2016, Prenatal Valproate Exposure Differentially Affects Parvalbumin-Expressing Neurons and Related Circuits in the Cortex and Striatum of Mice, Front. Mol. Neurosci., 9, 150, 10.3389/fnmol.2016.00150 · DOI
- Hou, 2018, A Developmental Study of Abnormal Behaviors and Altered GABAergic Signaling in the VPA-Treated Rat Model of Autism, Front. Behav. Neurosci., 12, 182, 10.3389/fnbeh.2018.00182 · DOI
- Qin, 2016, Valproic acid exposure sequentially activates Wnt and mTOR pathways in rats, Mol. Cell. Neurosci., 75, 27, 10.1016/j.mcn.2016.06.004 · DOI
- Zhang, 2018, Transcriptional and splicing dysregulation in the prefrontal cortex in valproic acid rat model of autism, Reprod. Toxicol., 77, 53, 10.1016/j.reprotox.2018.01.008 · DOI
- Kobayashi, 2019, Effects of rapamycin on social interaction deficits and gene expression in mice exposed to valproic acid in utero, Mol. Brain, 12, 3, 10.1186/s13041-018-0423-2 · DOI
- Hill, 2015, Autism-Like Behavior and Epigenetic Changes Associated with Autism as Consequences of in UteroExposure to Environmental Pollutants in a Mouse Model, Behav. Neurol., 2015, 426263, 10.1155/2015/426263 · DOI
- Bezgin, 2018, Developmental changes of cortical white-gray contrast as predictors of autism diagnosis and severity, Transl. Psychiatry, 8, 249, 10.1038/s41398-018-0296-2 · DOI
- Wang, 2018, Decreased Number and Expression of nNOS-Positive Interneurons in Basolateral Amygdala in Two Mouse Models of Autism, Front. Cell. Neurosci., 12, 251, 10.3389/fncel.2018.00251 · DOI
- Rubio, 1989, Acute changes in 5-HT metabolism after S-adenosyl-L-methionine administration, Gen. Pharmacol. Vasc. Syst., 20, 403, 10.1016/0306-3623(89)90186-9 · DOI
- Villalobos, 2000, Effect of S-adenosyl-l-methionine on rat brain oxidative stress damage in a combined model of permanent focal ischemia and global ischemia-reperfusion, Brain Res., 883, 31, 10.1016/S0006-8993(00)02873-0 · DOI
- Ortiz, 1997, Effects ofS-adenosyl-L-methionine on hepatic and renal oxidative stress in an experimental model of acute biliary obstruction in rats, Hepatology, 26, 121
- Li, 2017, S-Adenosylmethionine Attenuates Oxidative Stress and Neuroinflammation Induced by Amyloid-beta Through Modulation of Glutathione Metabolism, J. Alzheimers Dis., 58, 549, 10.3233/JAD-170177 · DOI
- Yoon, 2016, S-adenosylmethionine reduces airway inflammation and fibrosis in a murine model of chronic severe asthma via suppression of oxidative stress, Exp. Mol. Med., 48, e236, 10.1038/emm.2016.35 · DOI
- Morrison, 1996, Brain S-adenosylmethionine levels are severely decreased in Alzheimer’s disease, J. Neurochem., 67, 1328, 10.1046/j.1471-4159.1996.67031328.x · DOI · Paper page
- Mischoulon, 2014, A double-blind, randomized, placebo-controlled clinical trial of S-adenosyl-L-methionine (SAMe) versus escitalopram in major depressive disorder, J. Clin. Psychiatry, 75, 370, 10.4088/JCP.13m08591 · DOI
- Williams, 2005, S-adenosylmethionine (SAMe) as treatment for depression: A systematic review, Clin. Investig. Med., 28, 132
- Sharma, 2017, S-Adenosylmethionine (SAMe) for Neuropsychiatric Disorders: A Clinician-Oriented Review of Research, J. Clin. Psychiatry, 78, e656, 10.4088/JCP.16r11113 · DOI
- Sarris, 2015, Is S-Adenosyl Methionine (SAMe) for Depression Only Effective in Males? A Re-Analysis of Data from a Randomized Clinical Trial, Pharmacopsychiatry, 48, 141, 10.1055/s-0035-1549928 · DOI
- Ding, W., Higgins, D.P., Yadav, D.K., Godbole, A.A., Pukkila-Worley, R., and Walker, A.K. (2018). Stress-responsive and metabolic gene regulation are altered in low S-adenosylmethionine. PLoS Genet., 14. · doi:10.1101/346205
- Cho, 2017, Changes in brain metabolic connectivity underlie autistic-like social deficits in a rat model of autism spectrum disorder, Sci. Rep., 7, 13213, 10.1038/s41598-017-13642-3 · DOI
- Kim, 2017, Sex Differences in Autism-Like Behavioral Phenotypes and Postsynaptic Receptors Expression in the Prefrontal Cortex of TERT Transgenic Mice, Biomol. Ther., 25, 374, 10.4062/biomolther.2016.242 · DOI
- Nway, 2018, Social behavior, neuroimmune markers and glutamic acid decarboxylase levels in a rat model of valproic acid-induced autism, J. Toxicol. Sci., 43, 631, 10.2131/jts.43.631 · DOI
- Smith, 2012, NTS1 and NTS2 mediate analgesia following neurotensin analog treatment in a mouse model for visceral pain, Behav. Brain Res., 232, 93, 10.1016/j.bbr.2012.03.044 · doi:10.1016/j.bbr.2012.03.044
- Merullo, 2015, Neurotensin neural mRNA expression correlates with vocal communication and other highly-motivated social behaviors in male European starlings, Physiol. Behav., 151, 155, 10.1016/j.physbeh.2015.07.019 · DOI
- Gammie, 2009, Neurotensin inversely modulates maternal aggression, Neuroscience, 158, 1215, 10.1016/j.neuroscience.2008.11.045 · DOI
- Fitzpatrick, 2012, Altered Sleep and Affect in the Neurotensin Receptor 1 Knockout Mouse, Sleep, 35, 949, 10.5665/sleep.1958 · DOI
- Levitas-Djerbi, T., Sagi, D., Lebenthal-Loinger, I., Lerer-Goldshtein, T., and Appelbaum, L. (2019). Neurotensin Enhances Locomotor Activity and Arousal, and Inhibits Melanin-Concentrating Hormone Signalings. Neuroendocrinology, in press. · DOI
- Kinkead, 2006, Neurotensin: Role in psychiatric and neurological diseases, Peptides, 27, 2385, 10.1016/j.peptides.2006.04.024 · DOI
- Shilling, 2008, The neurotensin-1 receptor agonist PD149163 blocks fear-potentiated startle, Pharmacol. Biochem. Behav., 90, 748, 10.1016/j.pbb.2008.05.025 · DOI
- Cervo, 1992, Antidepressant-like effect of neurotensin administered in the ventral tegmental area in the forced swimming test, Psychopharmacology, 109, 369, 10.1007/BF02245885 · DOI
- Binder, 2001, Neurotensin and dopamine interactions, Pharmacol. Rev., 53, 453
- Dobner, 2005, Multitasking with neurotensin in the central nervous system, Cell. Mol. Life Sci., 62, 1946, 10.1007/s00018-005-5128-x · DOI
- Yin, 2008, Neurotensin reduces glutamatergic transmission in the dorsolateral striatum via retrograde endocannabinoid signaling, Neuropharmacology, 54, 79, 10.1016/j.neuropharm.2007.06.004 · DOI
- Kadiri, 2011, Neurotensin inhibits background K+ channels and facilitates glutamatergic transmission in rat spinal cord dorsal horn, Eur. J. Neurosci., 34, 1230, 10.1111/j.1460-9568.2011.07846.x · DOI
- Ferraro, 2008, Neurotensin receptors as modulators of glutamatergic transmission, Brain Res. Rev., 58, 365, 10.1016/j.brainresrev.2007.11.001 · DOI
- Rakovska, 1998, Neurotensin modulation of acetylcholine and gaba release from the rat hippocampus: An in vivo microdialysis study, Neurochem. Int., 33, 335, 10.1016/S0197-0186(98)00036-9 · doi:10.1016/s0197-0186(98)00036-9
- Rakovska, 2008, Neurotensin modulation of acetylcholine, GABA, and aspartate release from rat prefrontal cortex studied in vivo with microdialysis, Brain Res. Bull., 77, 129, 10.1016/j.brainresbull.2008.04.003 · DOI
- Petrie, 2005, Neurotensin Activates GABAergic Interneurons in the Prefrontal Cortex, J. Neurosci., 25, 1629, 10.1523/JNEUROSCI.3579-04.2005 · DOI
- Vincent, 1999, Neurotensin and neurotensin receptors, Trends Pharmacol. Sci., 20, 302, 10.1016/S0165-6147(99)01357-7 · DOI · Paper page
- Martin, 2003, Involvement of the Neurotensin Receptor-3 in the Neurotensin-Induced Migration of Human Microglia, J. Neurosci., 23, 1198, 10.1523/JNEUROSCI.23-04-01198.2003 · DOI
- Vadnie, 2014, Activation of neurotensin receptor type 1 attenuates locomotor activity, Neuropharmacology, 85, 482, 10.1016/j.neuropharm.2014.05.046 · DOI
- Keiser, 2014, Systemic administration of the neurotensin NTS-receptor agonist PD149163 improves performance on a memory task in naturally deficient male brown Norway rats, Exp. Clin. Psychopharmacol., 22, 541, 10.1037/a0037912 · DOI
- Angelidou, 2010, Neurotensin is increased in serum of young children with autistic disorder, J. Neuroinflamm., 7, 48, 10.1186/1742-2094-7-48 · DOI
- Tsilioni, 2014, Elevated serum neurotensin and CRH levels in children with autistic spectrum disorders and tail-chasing Bull Terriers with a phenotype similar to autism, Transl. Psychiatry, 4, e466, 10.1038/tp.2014.106 · DOI
- Patel, 2016, Neurotensin stimulates sortilin and mTOR in human microglia inhibitable by methoxyluteolin, a potential therapeutic target for autism, Proc. Natl. Acad. Sci. USA, 113, E7049, 10.1073/pnas.1604992113 · DOI
- Ghanizadeh, 2010, Targeting neurotensin as a potential novel approach for the treatment of autism, J. Neuroinflamm., 7, 58, 10.1186/1742-2094-7-58 · DOI
- Kirsten, T.B., Casarin, R.C., Bernardi, M.M., and Felicio, L.F. (2018). Pioglitazone abolishes autistic-like behaviors via the IL-6 pathway. PLoS ONE, 13. · DOI
- Kirsten, 2019, Pioglitazone abolishes cognition impairments as well as BDNF and neurotensin disturbances in a rat model of autism, Biol. Open, 8, bio041327, 10.1242/bio.041327 · DOI
- Normandeau, 2018, A Key Role for Neurotensin in Chronic-Stress-Induced Anxiety-Like Behavior in Rats, Neuropsychopharmacology, 43, 285, 10.1038/npp.2017.134 · DOI
- Lipstein, 2017, Synaptic UNC13A protein variant causes increased neurotransmission and dyskinetic movement disorder, J. Clin. Investig., 127, 1005, 10.1172/JCI90259 · DOI
- Damaj, 2015, CACNA1A haploinsufficiency causes cognitive impairment, autism and epileptic encephalopathy with mild cerebellar symptoms, Eur. J. Hum. Genet., 23, 1505, 10.1038/ejhg.2015.21 · DOI · Paper page
- Lee, 2012, Multi-locus genome-wide association analysis supports the role of glutamatergic synaptic transmission in the etiology of major depressive disorder, Transl. Psychiatry, 2, e184, 10.1038/tp.2012.95 · DOI
- Horder, 2013, Reduced subcortical glutamate/glutamine in adults with autism spectrum disorders: A [H] MRS study, Transl. Psychiatry, 3, e279, 10.1038/tp.2013.53 · DOI
- Bernardi, 2011, In vivo 1H-magnetic resonance spectroscopy study of the attentional networks in autism, Brain Res., 1380, 198, 10.1016/j.brainres.2010.12.057 · DOI
- Page, 2006, In Vivo 1 H-Magnetic Resonance Spectroscopy Study of Amygdala-Hippocampal and Parietal Regions in Autism, Am. J. Psychiatry, 163, 2189, 10.1176/ajp.2006.163.12.2189 · doi:10.1176/ajp.2006.163.12.2189
- Wickens, 2018, Sex Differences in Psychiatric Disease: A Focus on the Glutamate System, Front. Mol. Neurosci., 11, 197, 10.3389/fnmol.2018.00197 · DOI
- Gustavsson, 2014, Dopamine D1 receptor availability is related to social behavior: A positron emission tomography study, NeuroImage, 102, 590, 10.1016/j.neuroimage.2014.08.018 · DOI
- Homberg, 2016, The role of the dopamine D1 receptor in social cognition: Studies using a novel genetic rat model, Dis. Model. Mech., 9, 1147
- Canals, 2003, Adenosine A2A-dopamine D2 receptor-receptor heteromerization: Qualitative and quantitative assessment by fluorescence and bioluminescence energy transfer, J. Biol. Chem., 278, 46741, 10.1074/jbc.M306451200 · DOI · Paper page
- Collins, 2014, Opponent actor learning (OpAL): Modeling interactive effects of striatal dopamine on reinforcement learning and choice incentive, Psychol. Rev., 121, 337, 10.1037/a0037015 · DOI · Paper page
- Vorstman, 2006, The 22q11.2 deletion in children: High rate of autistic disorders and early onset of psychotic symptoms, J. Am. Acad. Child Adolesc. Psychiatry, 45, 1104, 10.1097/01.chi.0000228131.56956.c1 · DOI · Paper page
- Deckert, 1996, Human adenosine A2a receptor (A2aAR) gene: Systematic mutation screening in patients with schizophrenia, J. Neural Transm., 103, 1447, 10.1007/BF01271259 · DOI
- Hong, 2005, Association studies of the adenosine A2a receptor (1976T > C) genetic polymorphism in Parkinson’s disease and schizophrenia, J. Neural Transm., 112, 1503, 10.1007/s00702-005-0286-4 · DOI
- Hohoff, 2010, Adenosine A2A receptor gene: Evidence for association of risk variants with panic disorder and anxious personality, J. Psychiatr. Res., 44, 930, 10.1016/j.jpsychires.2010.02.006 · DOI
- Freitag, 2010, Adenosine A (2A) receptor gene (ADORA2A) variants may increase autistic symptoms and anxiety in autism spectrum disorder, Eur. Child Adolesc. Psychiatry, 19, 67, 10.1007/s00787-009-0043-6 · DOI
- Squillace, 2014, Dysfunctional dopaminergic neurotransmission in asocial BTBR mice, Transl. Psychiatry, 4, e427, 10.1038/tp.2014.69 · DOI
- Traynelis, 2010, Glutamate receptor ion channels: Structure, regulation, and function, Pharmacol. Rev., 62, 405, 10.1124/pr.109.002451 · DOI · Paper page
- Chen, 2017, Next-generation DNA sequencing identifies novel gene variants and pathways involved in specific language impairment, Sci. Rep., 7, 46105, 10.1038/srep46105 · DOI
- Gao, K., Tankovic, A., Zhang, Y., Kusumoto, H., Zhang, J., Chen, W., Xiangwei, W., Shaulsky, G.H., Hu, C., and Traynelis, S.F. (2017). A de novo loss-of-function GRIN2A mutation associated with childhood focal epilepsy and acquired epileptic aphasia. PLoS ONE, 12. · DOI
- Goswami, 2013, Gene expression analysis of novel genes in the prefrontal cortex of major depressive disorder subjects, Prog. Neuropsychopharmacol. Biol. Psychiatry, 43, 126, 10.1016/j.pnpbp.2012.12.010 · DOI
- Lee, 2011, Flt-1 regulates vascular endothelial cell migration via a protein tyrosine kinase-7–dependent pathway, Blood, 117, 5762, 10.1182/blood-2010-09-306928 · DOI
- Shibuya, 2006, Differential roles of vascular endothelial growth factor receptor-1 and receptor-2 in angiogenesis, J. Biochem. Mol. Biol., 39, 469
- Mahoney, E.R., Dumitrescu, L., Moore, A.M., Cambronero, F.E., De Jager, P.L., Koran, M.E.I., Petyuk, V.A., Robinson, R.A.S., Goyal, S., and Schneider, J.A. (2019). Brain expression of the vascular endothelial growth factor gene family in cognitive aging and alzheimer’s disease. Mol. Psychiatry, in press. · DOI · Paper page
- Hu, V.W., Frank, B.C., Heine, S., Lee, N.H., and Quackenbush, J. (2006). Gene expression profiling of lymphoblastoid cell lines from monozygotic twins discordant in severity of autism reveals differential regulation of neurologically relevant genes. BMC Genom., 7. · DOI · Paper page
- Maurer, 2017, The Cholinergic System Modulates Memory and Hippocampal Plasticity via Its Interactions with Non-Neuronal Cells, Front. Immunol., 8, 1489, 10.3389/fimmu.2017.01489 · DOI · Paper page
- Ballinger, 2016, Basal Forebrain Cholinergic Circuits and Signaling in Cognition and Cognitive Decline, Neuron, 91, 1199, 10.1016/j.neuron.2016.09.006 · DOI · Paper page
- Sarter, 2012, Cholinergic contributions to the cognitive symptoms of schizophrenia and the viability of cholinergic treatments, Neuropharmacology, 62, 1544, 10.1016/j.neuropharm.2010.12.001 · DOI
- Hardan, 2002, A Retrospective Open Trial of Adjunctive Donepezil in Children and Adolescents with Autistic Disorder, J. Child Adolesc. Psychopharmacol., 12, 237, 10.1089/104454602760386923 · DOI
- Wang, 2015, Modulation of social deficits and repetitive behaviors in a mouse model of autism: The role of the nicotinic cholinergic system, Psychopharmacology, 232, 4303, 10.1007/s00213-015-4058-z · DOI
- Perry, 2001, Cholinergic Activity in Autism: Abnormalities in the Cerebral Cortex and Basal Forebrain, Am. J. Psychiatry, 158, 1058, 10.1176/appi.ajp.158.7.1058 · DOI · Paper page
- Han, 2017, Author Correction: Down-regulation of cholinergic signaling in the habenula induces anhedonia-like behavior, Sci. Rep., 7, 17090, 10.1038/s41598-017-16991-1 · doi:10.1038/s41598-017-16991-1
- Bierer, 1995, Neurochemical correlates of dementia severity in Alzheimer’s disease: Relative importance of the cholinergic deficits, J. Neurochem., 64, 749, 10.1046/j.1471-4159.1995.64020749.x · DOI · Paper page
- Giannini, 1995, The ryanodine receptor/calcium channel genes are widely and differentially expressed in murine brain and peripheral tissues, J. Cell Boil., 128, 893, 10.1083/jcb.128.5.893 · DOI · Paper page
- Galeotti, 2008, Different involvement of type 1, 2, and 3 ryanodine receptors in memory processes, Learn. Mem., 15, 315, 10.1101/lm.929008 · DOI
- Pratt, 2015, Critical Role of Intracellular RyR1 Calcium Release Channels in Skeletal Muscle Function and Disease, Front. Physiol., 6, 420
- Kulkarni, M.M. (2011). Digital multiplexed gene expression analysis using the NanoString nCounter system. Curr. Protoc. Mol. Biol. · DOI · Paper page
- Sherman, 2009, Bioinformatics enrichment tools: Paths toward the comprehensive functional analysis of large gene lists, Nucleic Acids Res., 37, 1, 10.1093/nar/gkn923 · DOI · Paper page
- Salman, 2017, Transcriptome analysis suggests a role for the differential expression of cerebral aquaporins and the MAPK signalling pathway in human temporal lobe epilepsy, Eur. J. Neurosci., 46, 2121, 10.1111/ejn.13652 · DOI
- Salman, 2017, Transcriptome Analysis of Gene Expression Provides New Insights into the Effect of Mild Therapeutic Hypothermia on Primary Human Cortical Astrocytes Cultured under Hypoxia, Front. Cell. Neurosci., 11, 386, 10.3389/fncel.2017.00386 · DOI
- Kim, 2015, The NanoString-based multigene assay as a novel platform to screen EGFR, HER2, and MET in patients with advanced gastric cancer, Clin. Transl. Oncol., 17, 462, 10.1007/s12094-014-1258-7 · DOI
- Leal, 2018, Reproducibility of the NanoString 22-gene molecular subgroup assay for improved prognostic prediction of medulloblastoma, Neuropathology, 38, 475, 10.1111/neup.12508 · DOI
- Trubicka, 2018, Medulloblastoma with transitional features between Group 3 and Group 4 is associated with good prognosis, J. Neuro-Oncol., 138, 231, 10.1007/s11060-018-2797-5 · doi:10.1007/s11060-018-2797-5
- Zapka, 2018, Type, Frequency, and Spatial Distribution of Immune Cell Infiltrates in CNS Germinomas: Evidence for Inflammatory and Immunosuppressive Mechanisms, J. Neuropathol. Exp. Neurol., 77, 119, 10.1093/jnen/nlx106 · DOI
- Solomon, I.H., De Girolami, U., Chettimada, S., Misra, V., Singer, E.J., and Gabuzda, D. (2017). Brain and liver pathology, amyloid deposition, and interferon responses among older HIV-positive patients in the late HAART era. BMC Infect. Dis., 17. · DOI
- Prokopec, 2013, Systematic evaluation of medium-throughput mRNA abundance platforms, RNA, 19, 51, 10.1261/rna.034710.112 · DOI
- Oldridge, 1990, The health belief model: Predicting compliance and dropout in cardiac rehabilitation, Med. Sci. Sports Exerc., 22, 678, 10.1249/00005768-199010000-00020 · DOI
Cited by
Ornoy, A., Echefu, B., & Becker, M. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms251910469 · Cited by 41
Self-citationAhmed, O. G., Shehata, G. A., Ali, R. M., Makboul, R., Abd Allah, E. S. H., & Abd el-Rady, N. M. (2021) · Applied Physiology, Nutrition, and Metabolism · doi:10.1139/apnm-2020-0923 · Cited by 14
Metadata
- Authors
- Weinstein-Fudim, L., Ergaz, Z., Turgeman, G., Yanai, J., Szyf, M., & Ornoy, A.
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2019-10-24
- Volume
- 20
- Issue
- 21
- Pages
- 5278
- ISSN
- 1422-0067
- Cited by
- 27
- References
- 15
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Gender Related Changes in Gene Expression Induced by Valproic Acid in A Mouse Model of Autism and the Correction by S-adenosyl Methionine. Does It Explain the Gender Differences in Autistic Like Behavior? https://app.cochat.ai/papers/10.3390/ijms20215278
- The paper
- Weinstein-Fudim, L., Ergaz, Z., Turgeman, G., Yanai, J., Szyf, M., & Ornoy, A. (2019). Gender Related Changes in Gene Expression Induced by Valproic Acid in A Mouse Model of Autism and the Correction by S-adenosyl Methionine. Does It Explain the Gender Differences in Autistic Like Behavior? International Journal of Molecular Sciences. https://doi.org/10.3390/ijms20215278
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.